TriRx Pharmaceutical Services
Norwalk, CT
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (8)
○ EMA GMP
○ MHRA GMP
Quick Facts: TriRx Pharmaceutical Services
- Signal Score
- 60.0/100
- Quality Compliance
- Assessment pending
- Headquarters
- Norwalk, CT
- Modalities
- Non-sterile liquid fill, Creams / ointments / semi-solids, Solutions and suspensions, Sterile liquids, Biologics API, Solid dose, Animal health
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About TriRx Pharmaceutical Services
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesNon-sterile liquid fill, Creams / ointments / semi-solids, Solutions and suspensions, Sterile liquids, Biologics API, Solid dose, Animal health
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (7 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press8 articles
Broad modality coverage (7 modalities)
Recent News 8 articles
TriRx Enters Agreement for the Acquisition of Elanco Animal Health Facilities in Shawnee, Kansas and Speke, United Kingdom - PR Newswire
TriRx Completes Acquisition of Elanco Manufacturing Facility in Speke, United Kingdom - PR Newswire
TriRx Pharmaceutical Services acquires MSD Animal Health manufacturing site located in Segré-en Anjou Bleu, France including long-term supply agreement - PR Newswire
TriRx Partnership with Liverpool City Region Advances Biotech Capabilities - PR Newswire
Elanco completes sale of a pair of plants to CDMO TriRx in Kansas and UK - Fierce Pharma
Big Shawnee facility, employees officially change hands - The Business Journals
TriRx Completes Acquisition of Elanco Animal Health Facility in Shawnee, Kansas - PR Newswire
TriRx Partnership with Liverpool City Region Advances Biotech Capabilities - Contract Pharma
Represent this organization? Contact us to verify or update this profile.